EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 28-Jul-2025 10:11 ET (28-Jul-2025 14:11 GMT/UTC)

1-Jul-2025

NKAPL: a promising biomarker for NSCLC diagnosis and treatment

Compuscript Ltd
Peer-Reviewed Publication

Non-small cell lung cancer (NSCLC) is the most prevalent form of lung cancer, accounting for more than 80% of all lung cancers. While NF-kappa-B-activating protein-like (NKAPL) has been positively correlated with prognosis in various cancer types, its specific role in the progression of NSCLC remains undetermined.

Journal: Genes & Diseases
Funder: National Natural Science Foundation of China, Natural Science Foundation of Chongqing, China, Natural Science Foundation of Chongqing, China, Natural Science Foundation of Chongqing, China, Medical and Industrial Integration Project, Sichuan Science and Technology Program, China

30-Jun-2025

Developed an AI-based classification system for facial pigmented lesions

Kindai University
Peer-Reviewed Publication

A research team led by Haruyo Yamamoto, Chisa Nakashima, and Atsushi Otsuka from Department of Dermatology, Kindai University Faculty of Medicine, in collaboration with the Faculty of Engineering at Kindai University and other institutions, has developed a diagnostic system that uses artificial intelligence (AI) to accurately identify the type of facial pigmented lesions and support laser treatment decisions. A paper on this study was published online in Cureus, an international medical journal on June 5, 2025.

Journal: Cureus

30-Jun-2025

Uterine cancer rates predicted to rise, especially among Black women

Columbia University Irving Medical Center
Peer-Reviewed Publication

A new study forecasts a substantial rise in uterine cancer cases and deaths over the next three decades, with a disproportionate impact on Black women.

Journal: Cancer Epidemiology Biomarkers & Prevention
Funder: NIH/National Institutes of Health

30-Jun-2025

Breast cancer risk in younger women may be influenced by hormone therapy

NIH/Office of the Director
Peer-Reviewed Publication

Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast cancer risk in women before age 55. Researchers discovered that women treated with unopposed estrogen hormone therapy (E-HT) were less likely to develop the disease than those who did not use hormone therapy. They also found that women treated with estrogen plus progestin hormone therapy (EP-HT) were more likely to develop breast cancer than women who did not use hormone therapy. Together, these results could help to guide clinical recommendations for hormone therapy use among younger women.

Journal: The Lancet Oncology
Funder: NIH/National Institute of Environmental Health Sciences, NIH/National Cancer Institute

30-Jun-2025

Computational biochemist joins Rice with CPRIT recruitment award

Rice University
Grant and Award Announcement

Computational biochemist Linna An will join Rice’s Department of Biosciences with support from a $2 million award from the Cancer Prevention and Research Institute of Texas.

Funder: Cancer Prevention and Research Institute of Texas

30-Jun-2025

Groundbreaking cancer therapy clinical trial with US Department of Energy’s accelerator-produced actinium-225 set to begin this summer

DOE/Oak Ridge National Laboratory
Business Announcement

The Department of Energy’s (DOE) Isotope Program, within the Office of Science, will supply a U.S. based company with accelerator produced actinium-225 (Ac-225) in support of an upcoming U.S. clinical trial for cancer therapy for the first time. This is a significant milestone in the advancement of radiopharmaceutical development and cancer therapy because it opens a potential new pipeline for this lifesaving isotope.

30-Jun-2025

AI-assisted technique offers safe, effective, painless breast imaging alternative

California Institute of Technology
Peer-Reviewed Publication

A breast lesion evaluation technique developed by Caltech has now been tested on human patients and performs comparably to mammography and MRI without any of the risk or discomfort.

Journal: Nature Biomedical Engineering

30-Jun-2025

Leading cancer and metabolic disease expert Michael Karin joins Sanford Burnham Prebys

Sanford Burnham Prebys
Business Announcement

Michael Karin, PhD, has long been fascinated by what happens when inflammation—ideally a short-term burst of biological activity to promote healing or fight infection—turns chronic and potentially deadly.

He joined Sanford Burnham Prebys on June 30, 2025, where he will continue investigating how chronic inflammation can promote tumor formation. Karin also will serve as director of the new Center for Metabolic and Liver Diseases.

30-Jun-2025

Hospital Internacional de Colombia becomes first in Colombia and South America to join Mayo Clinic Care Network

Mayo Clinic
Business Announcement

Hospital Internacional de Colombia (HIC) and Mayo Clinic announced that HIC in Bucaramanga has joined the Mayo Clinic Care Network. HIC is the first hospital in Colombia and in South America to join the network, a group of carefully vetted health care organizations with special access to Mayo Clinic's knowledge and expertise.

30-Jun-2025

A new “link” to triple-negative breast cancer

Cold Spring Harbor Laboratory
Peer-Reviewed Publication

CSHL Professor David Spector and graduate student Wenbo Xu have discovered that the long non-coding RNA LINC01235 helps promote the formation of triple-negative breast cancer. Their findings offer potential inroads to new and much-needed therapies for this deadly disease.

Journal: Molecular Cancer Research
Funder: NIH/National Cancer Institute